LNAI
Lunai Bioworks Inc.
Price Chart
Latest Quote
$3.74
+0.27 (+7.78%)
Current Price
| Previous Close | $3.47 |
| Open | $3.42 |
| Day High | $3.80 |
| Day Low | $3.42 |
| Volume | 17,947 |
Stock Information
| Shares Outstanding | 4.53M |
| Total Debt | $1.41M |
| Cash Equivalents | $3.16M |
| Revenue | $21K |
| Net Income | $-128.28M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $16.96M |
| EPS (TTM) | $-61.52 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $13.81M |
| Sales | $21K |
| Income | $-128.28M |
| Book/sh | $-2.14 |
| Cash/sh | $0.70 |
| Employees | 29 |
Financial Ratios
| Quick Ratio | 0.16 |
| Current Ratio | 0.19 |
Returns & Margins
| ROA | -9.65% |
| ROE | -325.46% |
| Gross Margin | 100.00% |
| Operating Margin | -6815.30% |
Ownership
| Insider Ownership | 31.30% |
| Institutional Ownership | 2.76% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 809.70 |
| P/B | -1.75 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $3.05 |
| SMA50 | $2.69 |
| SMA200 | $6.28 |
| RSI | 59.11 |
| ATR | 0.6596 |
| Shares Float | 3.35M |
| Short Float | 8.72% |
| Short Ratio | 0.41 |
| Volatility | 0.36 |
| Rel Volume | 0.01 |
Performance History
| Week | -6.50% |
| Month | +77.25% |
| Quarter | +16.29% |
| 6 Months | -54.61% |
| YTD | -51.90% |
| Year | -86.87% |
| 3 Years | -92.70% |
| 5 Years | -99.21% |
| 10 Years | -99.21% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $3.74 | 17,947 |
| 2026-06-24 | $3.43 | 326,500 |
| 2026-06-23 | $4.30 | 297,300 |
| 2026-06-22 | $4.15 | 1,165,900 |
| 2026-06-18 | $3.78 | 1,042,800 |
| 2026-06-17 | $4.00 | 26,485,400 |
| 2026-06-16 | $2.85 | 19,332,500 |
| 2026-06-15 | $2.61 | 128,600 |
| 2026-06-12 | $2.41 | 52,800 |
| 2026-06-11 | $2.50 | 40,300 |
| 2026-06-10 | $2.26 | 29,300 |
| 2026-06-09 | $2.29 | 23,900 |
| 2026-06-08 | $2.37 | 36,400 |
| 2026-06-05 | $2.45 | 48,700 |
| 2026-06-04 | $2.92 | 52,900 |
| 2026-06-03 | $2.87 | 32,500 |
| 2026-06-02 | $2.98 | 74,700 |
| 2026-06-01 | $2.96 | 129,100 |
| 2026-05-29 | $3.08 | 135,000 |
| 2026-05-28 | $3.04 | 430,600 |
| 2026-05-27 | $2.62 | 494,000 |
| 2026-05-26 | $2.11 | 86,500 |
About Lunai Bioworks Inc.
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.
đ° Latest News
Why Did LNAI Stock Soar Over 100% In Pre-Market Trading Today?
Stocktwits âĸ 2026-06-17T10:30:10Z
BC-Most Active Stocks
Associated Press Finance âĸ 2026-03-26T14:30:18ZLunai Bioworks: Fiscal Q2 Earnings Snapshot
Associated Press Finance âĸ 2026-02-17T20:22:00ZLunai Bioworks: Fiscal Q1 Earnings Snapshot
Associated Press Finance âĸ 2025-11-14T21:44:55Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $725,684 | $2,434,771 | $706,964 | $372,844 |
| Total Expenses | $18,546,573 | $27,388,296 | $19,596,891 | $22,826,191 |
| Other Income Expense | $-158,851,578 | $-58,602,761 | $-19,380,201 | $-90,356,364 |
| Net Non Operating Interest Income Expense | $-609,338 | $-2,434,771 | $-706,964 | $-250,803 |
| Interest Expense Non Operating | $725,684 | $2,434,771 | $706,964 | $372,844 |
| Operating Expense | $18,546,573 | $27,388,296 | $19,596,891 | $22,826,191 |
| General And Administrative Expense | $17,880,050 | $24,557,608 | $15,318,198 | $14,329,801 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-178,007,489 | $-88,425,828 | $-39,684,056 | $-113,433,392 |
| Net Interest Income | $-609,338 | $-2,434,771 | $-706,964 | $-250,803 |
| Interest Income | $116,346 | - | - | $122,041 |
| Normalized Income | $-19,155,911 | $-29,823,067 | $-20,303,855 | $-42,051,864 |
| Net Income From Continuing And Discontinued Operation | $-178,007,489 | $-88,425,828 | $-39,684,056 | $-113,433,392 |
| Total Operating Income As Reported | $-188,966,002 | $-81,639,296 | $-38,556,891 | $-116,079,191 |
| Net Income Common Stockholders | $-178,007,489 | $-88,425,828 | $-39,684,056 | $-113,433,392 |
| Net Income | $-178,007,489 | $-88,425,828 | $-39,684,056 | $-113,433,392 |
| Net Income Including Noncontrolling Interests | $-178,007,489 | $-88,425,828 | $-39,684,056 | $-113,433,392 |
| Net Income Continuous Operations | $-178,007,489 | $-88,425,828 | $-39,684,056 | $-113,433,392 |
| Pretax Income | $-178,007,489 | $-88,425,828 | $-39,684,056 | $-113,433,358 |
| Special Income Charges | $-158,739,429 | $-58,602,761 | $-19,379,182 | $-90,356,373 |
| Interest Income Non Operating | $116,346 | - | - | $122,041 |
| Operating Income | $-18,546,573 | $-27,388,296 | $-19,596,891 | $-22,826,191 |
| Depreciation Amortization Depletion Income Statement | $129,095 | $121,859 | $113,496 | $123,590 |
| Depreciation And Amortization In Income Statement | $129,095 | $121,859 | $113,496 | $123,590 |
| Gross Profit | - | $0 | $0 | - |
| Per Share | ||||
| Diluted EPS | $-86.40 | $-72.80 | $-56.80 | $-172.80 |
| Basic EPS | $-86.40 | $-72.80 | $-56.80 | $-172.80 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $-18,974,836 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-18,301,132 | $-27,266,437 | $-19,483,395 | $-22,580,560 |
| Total Unusual Items | $-158,851,578 | $-58,602,761 | $-19,380,201 | $-90,356,364 |
| Total Unusual Items Excluding Goodwill | $-158,851,578 | $-58,602,761 | $-19,380,201 | $-90,356,364 |
| Reconciled Depreciation | $129,095 | $121,859 | $113,496 | $123,590 |
| EBITDA (Bullshit earnings) | $-177,152,710 | $-85,869,198 | $-38,863,596 | $-112,936,924 |
| EBIT | $-177,281,805 | $-85,991,057 | $-38,977,092 | $-113,060,514 |
| Diluted Average Shares | $2,063,274 | $1,218,894 | $703,317 | $656,600 |
| Basic Average Shares | $2,063,274 | $1,218,894 | $703,317 | $656,600 |
| Diluted NI Availto Com Stockholders | $-178,007,489 | $-88,425,828 | $-39,684,056 | $-113,433,392 |
| Impairment Of Capital Assets | $170,419,429 | $54,251,000 | $18,960,000 | $93,253,000 |
| Restructuring And Mergern Acquisition | $-11,680,000 | $3,048,183 | $419,182 | $-2,896,627 |
| Gain On Sale Of Security | $-112,149 | - | $-1,019 | $9 |
| Research And Development | $537,428 | $2,708,829 | $4,165,197 | $8,372,800 |
| Selling General And Administration | $17,880,050 | $24,557,608 | $15,318,198 | $14,329,801 |
| Other Gand A | $17,880,050 | $24,557,608 | $15,318,198 | $14,329,801 |
| Other Special Charges | - | $1,303,578 | - | - |
| Tax Provision | - | - | $0 | $34 |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-27,478,835 | $-27,383,060 | $-7,788,565 | $-636,420 |
| Total Assets | $8,230,840 | $163,129,450 | $58,300,796 | $84,632,663 |
| Total Non Current Assets | $7,184,208 | $161,131,807 | $55,735,391 | $75,067,525 |
| Non Current Prepaid Assets | $0 | $19,849 | - | - |
| Goodwill And Other Intangible Assets | $6,128,994 | $159,360,204 | $54,290,676 | $73,255,268 |
| Other Intangible Assets | $165,994 | $30,043 | $42,650,676 | $61,615,268 |
| Current Assets | $1,046,632 | $1,997,643 | $2,565,405 | $9,565,138 |
| Other Current Assets | $566,081 | $668,929 | $690,925 | $392,996 |
| Receivables | $0 | $1,108,247 | $0 | - |
| Cash Cash Equivalents And Short Term Investments | $480,551 | $220,467 | $1,874,480 | $9,172,142 |
| Cash And Cash Equivalents | $92,700 | $220,467 | $1,874,480 | $9,172,142 |
| Cash Financial | $92,700 | $220,467 | $1,874,480 | $9,172,142 |
| Other Non Current Assets | - | $19,849 | $21,741 | $68,635 |
| Other Receivables | - | $1,108,247 | - | - |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $9,343,197 | $2,230,529 | $2,750,467 | - |
| Total Debt | $10,173,491 | $3,786,938 | $5,593,956 | $7,016,483 |
| Long Term Debt And Capital Lease Obligation | $424,547 | $842,389 | $775,587 | $5,562,847 |
| Current Debt And Capital Lease Obligation | $9,748,944 | $2,944,549 | $4,818,369 | $1,453,636 |
| Current Debt | $9,435,897 | $2,450,996 | $4,624,947 | $1,200,000 |
| Other Current Borrowings | $245,000 | $245,000 | - | $1,200,000 |
| Long Term Debt | - | - | - | $4,577,148 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $29,580,681 | $31,152,306 | $11,798,685 | $12,013,815 |
| Total Non Current Liabilities Net Minority Interest | $424,547 | $842,389 | $775,587 | $5,562,847 |
| Current Liabilities | $29,156,134 | $30,309,917 | $11,023,098 | $6,450,968 |
| Other Current Liabilities | $1,008,282 | $12,605,361 | $184,733 | $2,564,003 |
| Current Notes Payable | $9,190,897 | $2,205,996 | $4,624,947 | $0 |
| Payables And Accrued Expenses | $18,398,908 | $14,760,007 | $6,019,996 | $2,433,329 |
| Payables | $12,555,839 | $9,448,683 | $5,296,823 | $1,401,867 |
| Accounts Payable | $12,555,839 | $9,448,683 | $5,296,823 | $1,401,867 |
| Other Non Current Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $-21,349,841 | $131,977,144 | $46,502,111 | $72,618,848 |
| Total Equity Gross Minority Interest | $-21,349,841 | $131,977,144 | $46,502,111 | $72,618,848 |
| Stockholders Equity | $-21,349,841 | $131,977,144 | $46,502,111 | $72,618,848 |
| Gains Losses Not Affecting Retained Earnings | $10,814,842 | $-170,846 | $-29,882 | $-30,436 |
| Other Equity Adjustments | $10,814,842 | $-170,846 | $-29,882 | $-30,436 |
| Retained Earnings | $-510,462,570 | $-332,455,081 | $-244,029,253 | $-204,345,197 |
| Other | ||||
| Ordinary Shares Number | $2,217,411 | $1,937,840 | $796,226 | $662,588 |
| Share Issued | $2,217,411 | $1,937,840 | $796,226 | $662,588 |
| Tangible Book Value | $-27,478,835 | $-27,383,060 | $-7,788,565 | $-636,420 |
| Invested Capital | $-11,913,944 | $134,428,140 | $51,127,058 | $78,395,996 |
| Working Capital | $-28,109,502 | $-28,312,274 | $-8,457,693 | $3,114,170 |
| Capital Lease Obligations | $737,594 | $1,335,942 | $969,009 | $1,239,335 |
| Total Capitalization | $-21,349,841 | $131,977,144 | $46,502,111 | $77,195,996 |
| Additional Paid In Capital | $478,280,146 | $464,587,224 | $290,554,875 | $276,989,179 |
| Capital Stock | $17,741 | $15,847 | $6,371 | $5,302 |
| Common Stock | $17,741 | $15,847 | $6,371 | $5,302 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $424,547 | $842,389 | $775,587 | $985,699 |
| Current Capital Lease Obligation | $313,047 | $493,553 | $193,422 | $253,636 |
| Current Accrued Expenses | $5,843,069 | $5,311,324 | $723,173 | $1,031,462 |
| Goodwill | $5,963,000 | $159,330,161 | $11,640,000 | $11,640,000 |
| Net PPE | $1,055,214 | $1,751,754 | $1,422,974 | $1,743,622 |
| Accumulated Depreciation | $-702,180 | $-578,340 | $-464,799 | $-357,478 |
| Gross PPE | $1,757,394 | $2,330,094 | $1,887,773 | $2,101,100 |
| Leases | $224,629 | $224,629 | $224,629 | $224,629 |
| Other Properties | $1,327,369 | $1,909,631 | $1,490,283 | $1,703,610 |
| Machinery Furniture Equipment | $205,396 | $195,834 | $172,861 | $172,861 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $387,851 | $0 | - | - |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-7,874,647 | $-11,041,860 | $-11,804,323 | $-15,737,492 |
| Operating Activities | ||||
| Operating Cash Flow | $-7,874,647 | $-10,971,430 | $-11,774,549 | $-15,732,336 |
| Cash Flow From Continuing Operating Activities | $-7,874,647 | $-10,971,430 | $-11,774,549 | $-15,732,336 |
| Operating Gains Losses | - | $1,303,578 | - | $18,168 |
| Investing Activities | ||||
| Investing Cash Flow | $-500,000 | $-1,260,179 | $-29,774 | $-5,156 |
| Cash Flow From Continuing Investing Activities | $-500,000 | $-1,260,179 | $-29,774 | $-5,156 |
| Capital Expenditure | - | $-70,430 | $-29,774 | $-5,156 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $2,376,181 | $3,000,000 | $4,011,823 | $4,676,399 |
| Financing Cash Flow | $8,382,772 | $10,517,455 | $4,515,056 | $4,250,464 |
| Cash Flow From Continuing Financing Activities | $8,382,772 | $10,517,455 | $4,515,056 | $4,250,464 |
| Net Other Financing Charges | $-971,231 | $-870,073 | $-1,121,767 | $-560,848 |
| Net Common Stock Issuance | $2,376,181 | $3,000,000 | $4,011,823 | $4,676,399 |
| Common Stock Issuance | $2,376,181 | $3,000,000 | $4,011,823 | $4,676,399 |
| Other | ||||
| Issuance Of Debt | $6,977,822 | $8,045,663 | $0 | - |
| Interest Paid Supplemental Data | $24,555 | $20,128 | $352,334 | $79,716 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $34 |
| End Cash Position | $92,700 | $220,467 | $1,874,480 | $9,172,142 |
| Beginning Cash Position | $220,467 | $1,874,480 | $9,172,142 | $20,664,410 |
| Effect Of Exchange Rate Changes | $-135,892 | $60,141 | $-8,395 | $-5,240 |
| Changes In Cash | $8,125 | $-1,714,154 | $-7,289,267 | $-11,487,028 |
| Proceeds From Stock Option Exercised | $0 | $341,865 | $1,625,000 | $134,913 |
| Net Issuance Payments Of Debt | $6,977,822 | $8,045,663 | $0 | $-560,848 |
| Net Long Term Debt Issuance | $6,977,822 | $8,045,663 | $0 | $-560,848 |
| Long Term Debt Issuance | $6,977,822 | $8,045,663 | $0 | - |
| Net Investment Purchase And Sale | $-500,000 | $0 | - | - |
| Purchase Of Investment | $-500,000 | $0 | - | - |
| Net Business Purchase And Sale | $0 | $-1,189,749 | $0 | - |
| Sale Of Business | $0 | $65,851 | $0 | - |
| Purchase Of Business | $0 | $-1,255,600 | $0 | - |
| Net PPE Purchase And Sale | $0 | $-70,430 | $-29,774 | $-5,156 |
| Purchase Of PPE | $0 | $-70,430 | $-29,774 | $-5,156 |
| Change In Working Capital | $5,860,009 | $8,811,854 | $4,305,157 | $1,415,111 |
| Change In Other Current Liabilities | $-42,563 | $11,284 | $-81,284 | $10,540 |
| Change In Payables And Accrued Expense | $3,605,511 | $8,826,550 | $3,316,146 | $941,667 |
| Change In Accrued Expense | $499,330 | $4,769,268 | $-578,809 | $-139,641 |
| Change In Payable | $3,106,181 | $4,057,282 | $3,894,955 | $1,081,308 |
| Change In Account Payable | $3,106,181 | $4,057,282 | $3,894,955 | $1,081,308 |
| Change In Prepaid Assets | $1,143,293 | $1,082,267 | $1,070,249 | $461,310 |
| Change In Receivables | $1,153,768 | $-1,108,247 | $46 | $1,594 |
| Other Non Cash Items | $-9,701,131 | $8,292,978 | $995,803 | $-2,599,415 |
| Stock Based Compensation | $3,313,291 | $4,673,129 | $3,535,051 | $5,490,602 |
| Unrealized Gain Loss On Investment Securities | $112,149 | $0 | - | - |
| Asset Impairment Charge | $170,419,429 | $54,251,000 | $18,960,000 | $93,253,000 |
| Depreciation Amortization Depletion | $129,095 | $121,859 | $113,496 | $123,590 |
| Depreciation And Amortization | $129,095 | $121,859 | $113,496 | $123,590 |
| Amortization Cash Flow | $9,902 | $8,296 | $6,175 | $14,995 |
| Amortization Of Intangibles | $9,902 | $8,296 | $6,175 | $14,995 |
| Depreciation | $119,193 | $113,563 | $107,321 | $108,595 |
| Net Income From Continuing Operations | $-178,007,489 | $-88,425,828 | $-39,684,056 | $-113,433,392 |
| Repayment Of Debt | - | $-870,073 | $-1,121,767 | $-560,848 |
| Net Short Term Debt Issuance | - | $4,275,151 | $0 | - |
| Short Term Debt Issuance | - | $4,275,151 | $0 | - |
| Long Term Debt Payments | - | $-870,073 | $-1,121,767 | $-560,848 |
| Gain Loss On Sale Of PPE | - | - | $0 | $18,168 |
Fetched: 2026-06-22